Chong Kun Dang to face uphill battle in cold drink market

Published: 2008-12-22 06:46:00

Updated: 2008-12-22 06:46:00

Chong Kun Dang Pharmaceutical will face an uphill battle in the domestic cold drink market to survive fierce competition with its rivals, including Dong-A Pharm.

Chong Kun Dang has launched Penzal drink but restricted its sales to eight wholesalers nationwide, raising complaints from other who...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK